In a growing number of studies, neuroprotective agents from natural products are involved in targeting PI3K/AKT signaling, thus contributing to the prevention and treatment of neurodegenerative diseases (NDDs) including Alzheimer’s disease (AD) and Parkinson’s disease (PD) [14,15]. The gene discussed is AKT1; the disease is Alzheimer disease.